Apotheek Tack: what changed
Apotheek Tack
Largest movements
- Cash -€43,812
down €43,812 (-15.4%), from €284,934 to €241,122
mainly Trade debts (-€110,544) and Contributions, distributions and other (-€65,000)
- Tangible fixed assets -€26,231
down €26,231 (-8.1%), from €324,508 to €298,277
of which Land and buildings: -€19,086
- Receivables within one year -€25,693
down €25,693 (-14.7%), from €174,497 to €148,805
of which Other amounts receivable: -€14,182
- Trade debts -€110,544
down €110,544 (-50.4%), from €219,334 to €108,789
- Other debts +€67,200
up €67,200 (+58.4%), from €115,018 to €182,218
- Debts after one year -€51,375
down €51,375 (-19.7%), from €260,749 to €209,374
- Depreciation -€32,164
down €32,164 (-55.1%), from €58,395 to €26,231
- Staff costs +€20,399
up €20,399 (+22.9%), from €89,010 to €109,409
- Gross operating margin +€10,228
up €10,228 (+4.1%), from €248,602 to €258,830
- Taxes +€5,247
up €5,247 (+39.0%), from €13,455 to €18,703
- Financial income +€4,892
up €4,892 (+133%), from €3,676 to €8,569
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,146,817 | €1,058,299 | -€88,518 | -7.7% |
| Fixed assets | 21/28 | €324,508 | €298,277 | -€26,231 | -8.1% |
| Tangible fixed assets | 22/27 | €324,508 | €298,277 | -€26,231 | -8.1% |
| Land and buildings | 22 | €294,464 | €275,378 | -€19,086 | -6.5% |
| Plant, machinery and equipment | 23 | €6,013 | €3,317 | -€2,696 | -44.8% |
| Furniture and vehicles | 24 | €24,031 | €19,582 | -€4,449 | -18.5% |
| Current assets | 29/58 | €822,309 | €760,022 | -€62,287 | -7.6% |
| Stocks and contracts in progress | 3 | €280,991 | €290,283 | +€9,292 | +3.3% |
| Stocks | 30/36 | €280,991 | €290,283 | +€9,292 | +3.3% |
| Amounts receivable within one year | 40/41 | €174,497 | €148,805 | -€25,693 | -14.7% |
| Trade receivables | 40 | €146,906 | €135,395 | -€11,511 | -7.8% |
| Other amounts receivable | 41 | €27,592 | €13,410 | -€14,182 | -51.4% |
| Current investments | 50/53 | €74,877 | €74,877 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €284,934 | €241,122 | -€43,812 | -15.4% |
| Deferred charges and accrued income | 490/1 | €7,010 | €4,936 | -€2,074 | -29.6% |
| Total equity and liabilities | 10/49 | €1,146,817 | €1,058,299 | -€88,518 | -7.7% |
| Equity | 10/15 | €482,948 | €483,232 | +€284 | +0.1% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Reserves | 13 | €282,948 | €283,232 | +€284 | +0.1% |
| Distributable reserves | 133 | €282,948 | €283,232 | +€284 | +0.1% |
| Amounts payable | 17/49 | €663,869 | €575,067 | -€88,802 | -13.4% |
| Amounts payable after more than one year | 17 | €260,749 | €209,374 | -€51,375 | -19.7% |
| Financial debts | 170/4 | €260,749 | €209,374 | -€51,375 | -19.7% |
| Amounts payable within one year | 42/48 | €401,279 | €361,561 | -€39,719 | -9.9% |
| Current portion of amounts payable after more than one year | 42 | €50,554 | €51,375 | +€821 | +1.6% |
| Trade debts | 44 | €219,334 | €108,789 | -€110,544 | -50.4% |
| Suppliers | 440/4 | €219,334 | €108,789 | -€110,544 | -50.4% |
| Taxes, remuneration and social security | 45 | €16,374 | €19,178 | +€2,804 | +17.1% |
| Remuneration and social security | 454/9 | €16,374 | €19,178 | +€2,804 | +17.1% |
| Other amounts payable | 47/48 | €115,018 | €182,218 | +€67,200 | +58.4% |
| Accrued charges and deferred income | 492/3 | €1,840 | €4,132 | +€2,292 | +125% |
| Remuneration, social security and pensions | 62 | €89,010 | €109,409 | +€20,399 | +22.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €58,395 | €26,231 | -€32,164 | -55.1% |
| Other operating charges | 640/8 | €3,379 | €3,664 | +€285 | +8.4% |
| Gross operating margin | 9900 | €248,602 | €258,830 | +€10,228 | +4.1% |
| Operating profit (loss) | 9901 | €97,817 | €119,525 | +€21,708 | +22.2% |
| Financial income | 75/76B | €3,676 | €8,569 | +€4,892 | +133% |
| Recurring financial income | 75 | €3,676 | €8,569 | +€4,892 | +133% |
| Financial charges | 65/66B | €47,969 | €44,108 | -€3,861 | -8.0% |
| Recurring financial charges | 65 | €47,969 | €44,108 | -€3,861 | -8.0% |
| Profit (loss) for the period before taxes | 9903 | €53,525 | €83,986 | +€30,462 | +56.9% |
| Income taxes | 67/77 | €13,455 | €18,703 | +€5,247 | +39.0% |
| Profit (loss) for the period | 9904 | €40,069 | €65,284 | +€25,214 | +62.9% |
| Profit (loss) for the period to be appropriated | 9905 | €40,069 | €65,284 | +€25,214 | +62.9% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.